Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Children with constitutional trisomy 21 (cT21, Down Syndrome, DS) are at a higher risk for both myeloid and B-lymphoid leukaemias. The myeloid leukaemias are often preceded by a transient neonatal pre-leukaemic syndrome, Transient Abnormal Myelopoiesis (TAM). TAM is caused by cooperation between cT21 and acquired somatic N-terminal truncating mutations in the key haematopoietic transcription factor GATA1. These mutations, which are not leukaemogenic in the absence of cT21, are found in almost one-third of neonates with DS. Analysis of primary human fetal liver haematopoietic cells and of human embryonic stem cells demonstrates that cT21 itself substantially alters human fetal haematopoietic development. Consequently, many haematopoietic developmental defects are observed in neonates with DS even in the absence of TAM. Although studies in mouse models have suggested a pathogenic role of deregulated expression of several chromosome 21-encoded genes, their role in human leukaemogenesis remains unclear. As cT21 exists in all embryonic cells, the molecular basis of cT21-associated leukaemias probably reflects a complex interaction between deregulated gene expression in haematopoietic cells and the fetal haematopoietic microenvironment in DS.

Original publication

DOI

10.1111/bjh.13096

Type

Journal article

Journal

Br J Haematol

Publication Date

12/2014

Volume

167

Pages

587 - 599

Keywords

Down syndrome acute lymphoblastic leukaemia, GATA1, acute megakaryoblastic leukaemia, transient abnormal myelopoiesis, trisomy 21, Adolescent, Animals, Child, Child, Preschool, Chromosomes, Human, Pair 21, Down Syndrome, GATA1 Transcription Factor, Gene Expression Regulation, Leukemic, Hematopoietic Stem Cells, Humans, Leukemia, B-Cell, Leukemia, Myeloid, Mice, Myelopoiesis, Neoplasm Proteins, Preleukemia, Stem Cell Niche